Abstract
National guidelines for treatment of ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hyponatremia have been approved by the Danish Society of Gastroenterology and Hepatology. Ascites develops in approximately 60% of patients with cirrhosis during a 10 year period and is frequently associated with complications that determine the course of the disease and the prognosis. These evidence-based guidelines are divided in two parts and consider definitions, pathophysiology, diagnostic aspects, treatment, and prophylaxis.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Ascites* / diagnosis
-
Ascites* / etiology
-
Ascites* / metabolism
-
Ascites* / physiopathology
-
Ascites* / therapy
-
Ascitic Fluid / metabolism
-
Ascitic Fluid / microbiology
-
Bacterial Infections / diagnosis
-
Bacterial Infections / microbiology
-
Bacterial Infections / physiopathology
-
Bacterial Infections / therapy
-
Clinical Protocols / standards
-
Combined Modality Therapy
-
Diuretics / therapeutic use*
-
Evidence-Based Medicine / standards
-
Humans
-
Liver Cirrhosis / complications*
-
Liver Cirrhosis / physiopathology
-
Microbial Sensitivity Tests
-
Paracentesis / methods*
-
Peritonitis* / diagnosis
-
Peritonitis* / microbiology
-
Peritonitis* / physiopathology
-
Peritonitis* / therapy
-
Suppuration / complications
-
Suppuration / physiopathology
Substances
-
Anti-Bacterial Agents
-
Diuretics